Key Highlights
- Advarra launches Oncology Research Pulse to foster collaboration in cancer research.
- Expert insights on trial efficiency, diversity, and regulatory compliance.
- Partnership with Fierce Pharma for a webinar series on oncology trial innovations.
- First webinar on April 10, 2025, featuring experts from City of Hope and Advarra.
- Coverage of major oncology conferences, including ASCO and AACI.
Source: Direct
Notable Quotes
- “Cancer research is evolving at an unprecedented pace. New therapies, shifting regulations, and cutting-edge technologies are transforming how trials are designed and conducted. Yet, persistent challenges remain—study startup is too slow, research sites are overburdened, and too many patients struggle to access innovative treatments.” – Christine Senn, PhD, Senior Vice President and Head of Site-Sponsor Innovation at Advarra
- “Collaboration is essential in overcoming the complexities of modern oncology research. Programs such as Oncology Research Pulse provide a valuable forum for key stakeholders to come together, share insights, and work toward practical solutions that improve trial efficiency and patient access.” – Walter Stadler, MD, FACP, Chief Clinical Officer, City of Hope at Chicago
Why This Matters
Oncology research is advancing rapidly, yet persistent challenges hinder clinical trial efficiency and patient access to life-saving treatments. Oncology Research Pulse aims to drive meaningful change by fostering industry-wide collaboration, exploring innovative trial methodologies, and addressing key issues like diversity and regulatory compliance. With expert-led discussions and partnerships, this initiative will help accelerate cancer research, improve patient outcomes, and shape the future of oncology clinical trials.
